Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Firebrick Pharma Limited ( (AU:FRE) ) is now available.
Firebrick Pharma Limited has announced the issuance of 1,000,000 unlisted options, set to expire on August 1, 2029, with an exercise price of $0.15. This move is part of previously announced transactions and reflects the company’s strategic efforts to enhance its financial structure and stakeholder value.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates within the pharmaceutical industry, focusing on the development and commercialization of innovative healthcare products.
Average Trading Volume: 74,945
Technical Sentiment Signal: Buy
See more data about FRE stock on TipRanks’ Stock Analysis page.